Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment.
Chiriac A, Grosu OM, Terinte C, Perţea M.
J Dermatolog Treat. 2020 Aug;31(5):545-548. doi: 10.1080/09546634.2019.1618435. Epub 2019 May 31.
Calcific Uremic Arteriolopathy Revisited.
Jovanovich A, Chonchol M.
J Am Soc Nephrol. 2016 Nov;27(11):3233-3235. doi: 10.1681/ASN.2016040480. Epub 2016 May 25.
Calcific uremic arteriolopathy: a call for action.
Brandenburg VM, Cozzolino M, Mazzaferro S.
Semin Nephrol. 2014 Nov;34(6):641-7. doi: 10.1016/j.semnephrol.2014.09.007.
Calcific uremic arteriolopathy.
Shetty M, Chowdhury Y, Yegneswaran B.
Cleve Clin J Med. 2018 Aug;85(8):584-585. doi: 10.3949/ccjm.85a.18009.
Multidisciplinary approach to calcific uremic arteriolopathy.
Nigwekar SU.
Curr Opin Nephrol Hypertens. 2015 Nov;24(6):531-7. doi: 10.1097/MNH.0000000000000175.
Calciphylaxis and Kidney Disease: A Review.
Gallo Marin B, Aghagoli G, Hu SL, Massoud CM, Robinson-Bostom L.
Am J Kidney Dis. 2023 Feb;81(2):232-239. doi: 10.1053/j.ajkd.2022.06.011. Epub 2022 Aug 12.
Calcific uremic arteriolopathy: advances in pathogenesis and treatment.
Rogers NM, Teubner DJ, Coates PT.
Semin Dial. 2007 Mar-Apr;20(2):150-7. doi: 10.1111/j.1525-139X.2007.00263.x.
Calcific uremic arteriolopathy: overview for the nurse.
Anderson KG.
AACN Adv Crit Care. 2013 Jul-Sep;24(3):285-300. doi: 10.1097/NCI.0b013e318291d9cb.
Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.
Sowers KM, Hayden MR.
Oxid Med Cell Longev. 2010 Mar-Apr;3(2):109-21. doi: 10.4161/oxim.3.2.11354.
Calciphylaxis: risk factors, diagnosis, and treatment.
Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM, Steele DJ, Thadhani RI.
Am J Kidney Dis. 2015 Jul;66(1):133-46. doi: 10.1053/j.ajkd.2015.01.034. Epub 2015 May 7.
